The Stanley Medical Research Institute (SMRI) is a nonprofit organization dedicated to supporting research on the causes and treatments of schizophrenia and bipolar disorder. Since its establishment in 1989, SMRI has provided over $550 million in research funding to more than 30 countries worldwide.
Through their Treatment Trial Grants program, SMRI supports the testing of medications for the treatment of schizophrenia and bipolar disorder, with a focus on generic and off-label medications. Additionally, SMRI conducts brain research, offering postmortem samples and various datasets to further understand these mental health conditions. Supported by organizations like the Stanley Neurovirology Lab at John Hopkins University, SMRI plays a crucial role in advancing knowledge and improving outcomes for individuals affected by schizophrenia and bipolar disorder.
Generated from the website